S
Saeed Fatenejad
Researcher at Yale University
Publications - 28
Citations - 4142
Saeed Fatenejad is an academic researcher from Yale University. The author has contributed to research in topics: Etanercept & Rheumatoid arthritis. The author has an hindex of 20, co-authored 25 publications receiving 4015 citations.
Papers
More filters
Journal ArticleDOI
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
Lars Klareskog,Désirée van der Heijde,Julien P de Jager,A. K. S. Gough,Joachim R. Kalden,Michel Malaise,Emilio Martin Mola,Karel Pavelka,Jacques Sany,L. Settas,Joseph Wajdula,Ronald Pedersen,Saeed Fatenejad,Marie Sanda +13 more
TL;DR: The combination of etanercept and methotrexate was significantly better in reduction of disease activity, improvement of functional disability, and retardation of radiographic progression compared with methotRexate or etanorcept alone.
Journal ArticleDOI
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
Désirée van der Heijde,Lars Klareskog,Vicente Rodriguez-Valverde,Catalin Codreanu,Horatiu Bolosiu,J Melo-Gomes,Jesus Tornero-Molina,Joseph Wajdula,Ronald Pedersen,Saeed Fatenejad,Tempo Study Investigators +10 more
TL;DR: Etanercept in combination with MTX reduced disease activity, slowed radiographic progression, and improved function more effectively than did either monotherapy over a 2-year period.
Journal Article
B cells process and present lupus autoantigens that initiate autoimmune T cell responses
TL;DR: A model of molecular mimicry whereby autoantigen-presenting B cells are generated by foreign cross-reactive determinants that can, in turn, elicit an autoimmune T cell response in non-autoimmune mice is supported.
Journal ArticleDOI
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis
D. van der Heijde,Lars Klareskog,Robert Landewé,George A W Bruyn,Alain Cantagrel,Patrick Durez,Gabriel Herrero-Beaumont,Yair Molad,Catalin Codreanu,Gabriele Valentini,R. Zahora,Ronald Pedersen,D. MacPeek,Joseph Wajdula,Saeed Fatenejad +14 more
TL;DR: Etanercept plus methotrexate showed sustained efficacy through 3 years and remained more effective than either monotherapy, even after adjustment for patient withdrawal.
Journal ArticleDOI
Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
Robert Landewé,Désirée van der Heijde,Lars Klareskog,Ronald F van Vollenhoven,Saeed Fatenejad +4 more
TL;DR: Combination therapy with MTX plus etanercept uncouples the classic relationship between disease activity and radiographic progression in patients with RA.